Use of opioid analgesics in skin disorders: Results from a nationally representative US sample

References

• Yaksh T, Wallace M. Opioids, analgesia and pain management. In: Brunton LL, ed. Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 12th ed. New York: McGraw-Hill Medical, 2011. p 481–525
   Google Scholar
• United Nations. Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purposes 2010. New York: United Nations, 2011
   Google Scholar
• Executive Office of the President of the United States. Epidemic: responding to America’s Prescription Drug Abuse Crisis 2011. Available from http://www.whitehouse.gov/sites/default/files/ondcp/issues-content/prescription-drugs/rx_abuse_plan.pdf. Accessed March 30, 2014
   Google Scholar
• Harris K, Curtis J, Larsen B, et al. Opioid pain medication use after dermatologic surgery: a prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol. 2013;149:317–21
   PubMed Web of Science ®Google Scholar
• Giuggioli D, Manfredi A, Colaci M, Ferri C. Oxycodone in the long-term treatment of chronic pain related to scleroderma skin ulcers. Pain Med. 2010;11:1500–3
   Google Scholar
• Krajnik M, Zylicz Z, Finlay I, et al. Potential uses of topical opioids in palliative care – report of 6 cases. Pain. 1999;80:121–5
   Google Scholar
• Zylicz Z, Krajnik M. Codeine for pruritus in primary billiary cirrhosis. Lancet. 1999;353:813
   Google Scholar
• Ozil C, Vialle R, Thevenin-Lemoine C, et al. Use of a combined oxygen/nitrous oxide/morphine chlorydrate protocol for analgesia in burned children requiring painful local care. Pediatr Surg Int. 2010;26:263–7
   Google Scholar
• Xander C, Meerpohl JJ, Galandi D, et al. Pharmacological interventions for pruritus in adult palliative care patients. Cochrane Database Syst Rev. 2013;6:CD008320
   Google Scholar
• Inui S. Nalfurafine hydrochloride for treatment of pruritus. Expert Opin Pharmacother. 2012;13:1507–13
   PubMed Web of Science ®Google Scholar
• Nakatsuka N, Minogue S, Lim J, et al. Intravenous nalbuphine 50 μg·kg–1 is ineffective for opioid-induced pruritus in pediatrics. Can J Anaesth. 2006;53:1103–10
   Google Scholar
• Morgan P, Mehta S, Kapala D. Nalbuphine pretreatment in cesarean section patients receiving epidural morphine. Reg Anesth. 1991;16:84–8
   Google Scholar
• Davies G, From R. A blinded study using nalbuphine for prevention of pruritus induced by epidural fentanyl. Anesthesiology. 1988;69:763–5
   Google Scholar
• Du BX, Song ZM, Wang K, et al. Butorphanol prevents morphine-induced pruritus without increasing pain and other side effects: a systematic review of randomized controlled trials. Can J Anaesth. 2013;60:907–17
   Google Scholar
• Dawn AG, Yosipovitch G. Butorphanol for treatment of intractable pruritus. J Am Acad Dermatol. 2006;54:527–31
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics CDC. Ambulatory Health Care Data. Available from http://www.cdc.gov/nchs/ahcd.htm. Accessed March 15, 2014
   Google Scholar
• Ahn CS, Allen MM, Davis SA, et al. The National Ambulatory Medical Care Survey: a resource for understanding the outpatient dermatology treatment. J Dermatolog Treat. 2014;25:453–8
   PubMed Web of Science ®Google Scholar
• Gupta MA, Gupta AK, Fink NH. Polypharmacy in dermatology: analysis of a nationally representative sample of 46,273 dermatology patient visits in the United States from 1995 to 2009. Skinmed. 2013;11:273–80
   Google Scholar
• Gupta MA, Gupta AK, Vujcic B. Increased frequency of Attention Deficit Hyperactivity Disorder (ADHD) in acne versus dermatologic controls: analysis of an epidemiologic database from the US. J Dermatolog Treat. 2014;25:115–18
   PubMed Web of Science ®Google Scholar
• American Medical Association (AMA). International Classification of Diseases, 9th Revision. Clinical Modification (ICD9-CM). Salt Lake City, Utah: AMA; 2003
   Google Scholar
• Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. JAMA. 2008;299:70–8
   PubMed Web of Science ®Google Scholar
• Hudson TJ, Edlund MJ, Steffick DE, et al. Epidemiology of regular prescribed opioid use: results from a national, population-based survey. J Pain Symptom Manage. 2008;36:280–8
   PubMed Web of Science ®Google Scholar
• Tamayo-Sarver JH, Cydulka RK, Baker DW. Racial and ethnic disparities in emergency department analgesic prescription. Am J Public Health. 2003;93:2067–73
   PubMed Web of Science ®Google Scholar
• National Center for Health Statistics CDC. The New Ambulatory Care Drug Database System; 2012. Available from http://www2.cdc.gov/drugs/applicationnav1.asp. Accessed March 15, 2014
   Google Scholar
• Pallin DJ, Egan DJ, Pelletier AJ, et al. Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus. Ann Emerg Med 2008;51:291–8
   PubMed Web of Science ®Google Scholar
• IBM. SPSS Statistics for Windows, Complex Samples, 22.0 ed. Armonk, NY: IBM, 2013
   Google Scholar
• Hertz S, Avigan M. Memorandum to the File NDA 10-997 Darvon (propoxyphene hydrochloride) Capsules, NDA 16-862 Darvon-N (propoxyphene napsylate and acetaminophen) Tablets, NDA 17-122 Darvocet-N 50 and Darvocet-N 100 (propoxyphene napsylate and acetaminophen) Tablets. 2010. Available from http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM234349.pdf. Accessed March 16, 2014
   Google Scholar
• National Center for Health Statistics CDC. Ambulatory Health Care Data. Reliability of estimates. 2010. Available from http://www.cdc.gov/nchs/ahcd/ahcd_estimation_reliability.htm. Accessed March 15, 2014
   Google Scholar
• Drug Enforcement Administration. Drug Scheduling 2013. Available from http://www.justice.gov/dea/druginfo/ds.shtml. Accessed March 16, 2014
   Google Scholar
• IMS Institute for Healthcare Informatics. The use of medicines in the United States: review of 2011; 2012. Available from http://www.imshealth.com/ims/Global/Content/Insights/IMS%20Institute%20for%20Healthcare%20Informatics/IHII_Medicines_in_U.S_Report_2011.pdf. Accessed March 16, 2014
   Google Scholar